SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-107817
Filing Date
2020-09-23
Accepted
2020-09-23 16:17:32
Documents
2
Period of Report
2020-09-21
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2031479-1_8k.htm 8-K 34892
2 EXHIBIT 3.1 tm2031479d1_ex3-1.htm EX-3.1 54134
  Complete submission text file 0001104659-20-107817.txt   90594
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36435 | Film No.: 201192250
SIC: 2836 Biological Products, (No Diagnostic Substances)